AID WORKS (ON AVERAGE) Toby Ord President, Giving What We Can Research Fellow, Oxford University

Similar documents
MALARIA CONTROL as a best practice Corporate Social Responsibility Programme

Repellent Soap. The Jojoo Mosquito. Africa s innovative solution to Malaria prevention. Sapphire Trading Company Ltd

Resolution adopted by the General Assembly. [without reference to a Main Committee (A/62/L.39 and Add.1)]

What are the Millennium goals? There are 8 Millennium Development Goals (MDGs) which the UN set out to achieve by 2015:

Ready to beat malaria

Purposes of this lecture Promote holistic concepts of health which empower the individual to make informed and wise health choices.

Monitoring the achievement of the health-related Millennium Development Goals

Peter Attia had just become the first person to swim from Maui to Lanai and back (a 25-mile round trip). Age: 35 Weight: 200 lbs.

Why does Diarrhea matter? PREVENTING MORE THAN ONE MILLION UNNECESSARY DEATHS EVERY YEAR

IMPACT OF DEVELOPMENT ASSISTANCE FOR HEALTH ON COUNTRY SPENDING

Script for Contacting People that you Know

The Unfinished Agenda in Global Health. Richard Skolnik

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Toyako Framework for Action on Global Health - Report of the G8 Health Experts Group -

All About Vaccines and How They Get to Those Who Need Them Most. Elesha Kingshott

Sanofi updates information on dengue vaccine. 29 November 2017 (Sanofi Press Release)

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

The Struggle with Infectious Disease. Lecture 2

Investing for a Malaria-Free World

Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines

Part I. Health-related Millennium Development Goals

INVESTING FOR A MALARIA-FREE WORLD

Key Messages for World Malaria Day 2009

World Health Report 2019 Predictions

combat HIV/AIDS, malaria and other diseases

5 $3 billion per disease

Chapter 9 Nations, Nation-States, and Internationalism Related Issue #3: Should internationalism be pursued?

Economics of Vaccine Development A Vaccine Manufacturer s Perspective

TB Vaccine Development Strategy Overview

Fact sheet. Poliomyelitis. WHO Media centre. ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM

Copenhagen, Denmark, September August Malaria

Roadmaps as a Vehicle for Addressing Large- Scale Public Health Challenges: Lessons from the Malaria Vaccine Technology Roadmap

An Uncured Disease. By: Katie Farley. A disease so prominent, so recently discovered and so deadly has

Malaria. Dr Zia-Ul-Ain Sabiha

STATEMENT OF LYNN STRATFORD SENIOR VICE PRESIDENT, PROGRAM AND COMMUNITY ENGAGEMENT UNITED STATES FUND FOR UNICEF

ustainable Development Goals

Chapter 8 notes Human Capital: Education and Health (rough notes, use only as guidance; more details provided in lecture)

The protective power of vaccination

The Welsh Liberal Democrats plan to provide an effective cancer strategy for Wales

The protective power of vaccination

Summary World Malaria Report 2010

Harnessing the power of vaccines using the public and private sector: A 21 st century model for international development

VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine

Disease Control Priorities. Presentation Sub-title Seventh International Rotavirus Symposium Lisbon June 12, 2006

AOHS Global Health. Unit 1, Lesson 3. Communicable Disease

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine

26/06/ NIMR 2018 Conference - Malaria - a reality

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Published in WER 4 June, 2010

Infectious Disease Surveillance in NZ. Michael Baker Department of Public Health, University of Otago, Wellington

HEALTH ORGANISATIONS. National Health Programme

Malaria and Global Warming. Jocelyn Maher & Mickey Rowe

Background. Proposed to develop a framework for action. Address by Foreign Minister Koumura

Running Head: VECTOR-BORNE DISEASES: MALARIA IN CHILDREN 1

Cholera. Report by the Secretariat

The development and introduction of vaccines for the developing world

Vaccine Financing and Delivery: Room for Improvement

Recipients of development assistance for health

In the Name of God, the Compassionate, the Merciful. Address by DR HUSSEIN A. GEZAIRY REGIONAL DIRECTOR WHO EASTERN MEDITERRANEAN REGION.

A Hopeful Beginning for Malaria Vaccines

Leprosy control, elimination & eradication

ENDING AIDS, TB AND MALARIA AS EPIDEMICS

Check Against Delivery

CRS Report for Congress

128th Session 25 November 2010 Provisional agenda item Malaria. Prevention and control: sustaining the gains and reducing transmission

Revised Strategy for Malaria Control in the South-East Asia Region

~Health and Development Initiative~

Achieve universal primary education

measles? Abstract Introduction JUNE 2017 routine vaccination to 1 year old babies, and the second dose to

OPERATIONAL FRAMEWORK. for the Global Strategy for Women s, Children s and Adolescents Health

Towards a Cultural History of Malaria Treatment and Control: Institutions, Methods, and Metaphors

SMALLPOX EXPERIENCE Kazunobu Kojima, World Health Organization

1 We need to invest more in vaccines

DIARRHEAL DISEASE MESSAGING

CHILD HEALTH. There is a list of references at the end where you can find more information. FACT SHEETS

Monitoring and Evaluation IN ACTION! Duff Gillespie

Vaccine Development in the Developing World; past, present and future: SEAR Perspective

New vaccine technologies: Promising advances may save more lives

WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES

The Struggle with Infectious Disease. Lecture 2

Introduction: Statistics, Data and Statistical Thinking Part II

Ending Malaria in Nigeria: The WHO Agenda

USAID Progress: The U.S. National Vaccine Plan of 1994

FACTS FIGURES A FUTURE

CS/PoliSci/Statistics C79 Societal Risks & The Law

KURUKSHETRA JULY 2017 RURAL HEALTH

Resolution adopted by the General Assembly on 11 September [without reference to a Main Committee (A/69/L.91 and Add.1)]

Assessment Schedule 2013 Health: Analyse an international health issue (91462)

Mathematical Modeling of Infectious Diseases

Testimony Sarah Stoesz, President and CEO Planned Parenthood MN ND SD

Global Consultation on Child and Adolescent Health and Development 13 March 2002 Stockholm, Sweden

Testimony of John K. Roman Justice Policy Center Urban Institute

MINISTERIAL CONFERENCE ON MALARIA

malaria epidemics FD90C2A80F37419F A1B6C58 Malaria Epidemics 1 / 6

Analysis of the demand for a malaria vaccine: outcome of a consultative study in eight countries

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m.

Published analysis of London mortality data in 1662 Recognized patterns and trends such as male- female disparities and high infant mortality

Overview. Vaccine innovation With people, for people: The (A) citizens' view. Vaccine impact in perspective. Vaccine research in perspective

WHO: Forum Issue #02 Student Officer Position:

INVESTING IN A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA

The new WHO global injection safety policy and campaign

Transcription:

AID WORKS (ON AVERAGE) Toby Ord President, Giving What We Can Research Fellow, Oxford University

INTRODUCTION

Moyo So there we have it: sixty years, over US$1 trillion dollars of African aid, and not much good to show for it. Since the 1940s, approximately US$1 trillion of aid has been transferred from rich countries to Africa. This is nearly $1,000 for every man, woman and child on the planet today.

Moyo $1 trillion / 7 billion (world pop) = $142 per person = $2.38 per year per person $1 trillion / 440 million (average pop of SSA through period) = $2,263 per recipient = $38 per year per recipient not much good to show for it. Life expectancy in 1950 = 37.1 years Life expectancy in 2010 = 55.0 years Gain = 17.9 years = 48%

Easterly $2.3 trillion in aid but so little good c.f. Rumsfeld s 10 Sep 2001 speech US military has lost track of $2.3 trillion

Easterly One chapter devoted to health aid Reports strong evidence that it works Spends 2 pages on admitted successes, then 24 pages on AIDS Although the aid agencies have not calculated the aid impact in a scientifically rigorous way, the broad facts support the belief that aid was effective in many of the above health interventions. Alas, instead of expanding success in the many health areas where it had triumphed, the international health community was going to get bogged down in its equivalent of Vietnam: AIDS.

Riddell Looks at whether things work across many sectors. Mentions smallpox eradication and river blindness control as examples of clear successes (with figures) But doesn t dwell on just how successful they were e.g. smallpox eradication did 200x more, with less money

SEEKING CLARITY

Does Aid Work? Does aid produce economic growth? Do different aid sectors work? Does some aid have negative effects? Does the typical aid dollar work? What proportion of aid works?

What do we know already? Evidence of the effects of aid on economic growth is weak It might have no effect It might have a positive effect It might have a negative effect Some aid achieves nothing Some aid makes things worse Some aid makes things better Especially clear in global health

My Central Question Does the average aid dollar do enough to make aid a good deal overall?

Measured Cost-Effectiveness of Health

Measured Cost-Effectiveness of Health worth the cost

Measured Cost-Effectiveness of Health worth the cost

The Aid Effectiveness Landscape

The Aid Effectiveness Landscape most beneficial most harmful

The Aid Effectiveness Landscape total benefit total harm

The Aid Effectiveness Landscape proportion that is beneficial

The Aid Effectiveness Landscape worth the cost proportion that is beneficial proportion that is worth the cost

The Aid Effectiveness Landscape average effect worth the cost average net gains from aid

The Aid Effectiveness Landscape

The Aid Effectiveness Landscape

The Aid Effectiveness Landscape

SMALLPOX

Smallpox Scourge of humanity for thousands of years Distinctive rash Highly infectious Kills 1 in 3 infected people (in about 10 days) Kills 80% of infected children Blinds 10% of survivors In China and India people invented smallpox gods

War Smallpox

War Smallpox

War Smallpox 160 240 million

War Smallpox 160 240 million 300 500 million

c. 1000 Inoculation

1796 Vaccination

1959 World Health Assembly Resolution

The Jet Injector

Bifurcated Needle

Freeze Dried Vaccine

1967 Intensified Eradication Programme

1968 Surveillance and Containment

1977 Last Natural Case

1978 Last Death

1979 Certified Eradication

The Most Crucial Components The World Health Organization Was a focal point for passing resolutions and uniting the world s will United world medical and scientific expertise Coordinated a world programme, which distributed vaccine and skills Heat stable vaccine The Surveillance and Containment Strategy Financing

Finances Costs (1967 1979) Current $ International Endemic Countries Total $0.5 billion $1.0 billion $1.5 billion Savings (annual) Current $ US Endemic Countries $1.0 billion $7.4 billion

War Smallpox 20 th C 160 240 million 300 500 million

War Smallpox 20 th C 160 240 million 300 500 million Per Year average: 1.6 2.4 million average: 3 5 million early: >5 million 1950: 3 million 1967: 1.5 2 million

War Smallpox 20 th C 160 240 million 300 500 million Per Year average: 1.6 2.4 million average: 3 5 million early: >5 million 1950: 3 million 1967: 1.5 2 million Lives Saved 60 120 million

Cost-Effectiveness

Cost-Effectiveness $1.5 billion / 60 million lives saved = $25 per life saved Total aid spending so far Moyo says $1 trillion to Africa Easterly says $2.3 trillion total I ll conservatively update this to $4 trillion total $4 trillion / 60 million lives saved = $67,000 per life saved = one percent of what the US govt. will spend to save a life = about what the NHS will spend to save two years of life Enough to make aid effective on average Even if we only count a third (or a tenth!) of the lives saved as due to aid

OTHER BIG WINS Malaria, Diarrheal Disease, & Immunization

Other Immunization Measles is estimated to have killed 200 million over last 150 years Measles mortality is 0.1% in rich countries, 10% in poor ones Measles is now on its way to eradication Annual deaths from immunization preventable illnesses cut from 5 million in 1960 to 1.4 million in 2001

Malaria Mosquito borne blood parasite Causes fever and occasional death Nets, indoor spraying, medicine 2011 international funding: $1.84 billion 2011 local funding: Annual malaria deaths cut from 3.8 million to about 0.7 million Potentially eradicable $0.63 billion

Diarrhoeal Illness Cholera and other illnesses IV therapy introduced in 1831 Cut mortality from 70% to 40% Oral Rehydration Therapy in 1968 Rose to prominence during the Bangladesh Liberation War Cut mortality from 30% to 3.6% And was simpler and cheaper Incredibly cheap and simple Cut annual diarrhoeal deaths from 4.6 million to 1.6 million

Summary Deaths per year 1960 2001 1980 2001 1930 2010 1950 1979 average Immunizable Diarrhoeal Malaria Smallpox War

What have the Romans ever done for us? not much good to show for it Moyo so little good Easterly

What have the Romans ever done for us? not much good to show for it Moyo so little good Easterly All right, all right but apart from better sanitation and medicine and education and irrigation and public health and roads and a freshwater system and baths and public order... what have the Romans done for us? Monty Python

CONCLUSIONS

Conclusions Aid is complicated Some aid works, some doesn t The best aid has been astoundingly good It has been one of the best things in world history It has saved more lives than world peace would It has been enough to make aid work on average even if all other aid was worthless We need to pay great attention to cost-effectiveness in aid We should be quantitative and look for the really big wins